![[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof](/docs/US/2024-03-05/US11919896B2/abs.jpg.600x600.jpg)
- 专利标题： [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof
-
申请号： US17263416申请日： 2019-08-23
-
公开(公告)号： US11919896B2公开(公告)日： 2024-03-05
- 发明人: Weiwei Mao , Wenyuan Qian , Xuejian Zheng , Guoping Hu , Changqing Wei , Jian Li , Shuhui Chen
- 申请人： Zhuhai United Laboratories Co., Ltd.
- 申请人地址： CN Guangdong
- 专利权人： ZHUHAI UNITED LABORATORIES CO., LTD.
- 当前专利权人： ZHUHAI UNITED LABORATORIES CO., LTD.
- 当前专利权人地址： CN Guangdong
- 代理机构： Lucas & Mercanti, LLP
- 优先权： CN 1810968207.6 2018.08.23
- 国际申请： PCT/CN2019/102209 2019.08.23
- 国际公布： WO2020/038457A 2020.02.27
- 进入国家日期： 2021-01-26
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61P19/02
![[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof](/abs-image/US/2024/03/05/US11919896B2/abs.jpg.150x150.jpg)
摘要：
Disclosed are a [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and an application thereof in preparing a drug for treating a disease related to JAK1 or/and TYK2. Specifically, the present invention relates to a compound represented by formula (I), or an isomer or pharmaceutically acceptable salt thereof. (I)
公开/授权文献
信息查询
